Influence of all-trans retinoic acid(ATRA) on the expression of NANOG in Glioma cell lines

被引:0
|
作者
Liu Weixian
机构
关键词
retinoic acid; glioma; reverse transcriptase-polymerase chain reaction; immunocytochemistry; NANOG protein;
D O I
暂无
中图分类号
R739.4 [神经系肿瘤];
学科分类号
100214 ;
摘要
Objective To investigate the effects of all-trans retinoic acid(ATRA) on the expression of NANOG in glioma cell lines.Methods Each cell line was divided into the experimental group which was treated with ATRA for 5 days,and the control group which was cultured normally without ATRA treatment.Immunocytochemistry and RT-PCR were adopted to detect the expression of NANOG at protein and mRNA level among the three kinds of cell lines.Results Positive rates of NANOG protein in glioma cell lines SHG-44,U87 MG and U251 in control groups were(65.5±3.0)%,(64.8±8.0)% and(64.5±1.2)%,respectively,and the difference was not statistically significant(F=0.190,P=0.829).NANOG mRNA of the three cell lines in the relative content were 0.636 8±0.039 9,0.642 1±0.063 7,0.651 6±0.044 4,and the difference was not statistically significant(F=0.427,P=0.662).However,5 days after application of ATRA-induced NANOG protein in the three cell lines,the positive rates of NANOG protein of experimental groups were(36.5±7.3)%,(35.5±7.9)%,(35.2±6.1)%,respectively,compared with the control groups,the differences were statistically significant(FSHG-44=259.1,FU87=129.5,FU251= 431.8,PSHG-44=0.0,PU87=0.0,PU251=0.0),and the relative level of NANOG mRNA in these groups were 0.458 3±0.079 1,0.255 1±0.079 3 and 0.333 1±0.054 0,respectively,compared with the control groups,the difference was significant(FSHG-44=77.8,FU87=277.9,FU251=398.1,PSHG-44=0.0,PU87=0.0,PU251=0.0).Conclusion NANOG which highly expressed in glioma cell line SHG-44,U87 MG and U251 can be reduced by ATRA.
引用
收藏
页码:625 / 629 +620
页数:6
相关论文
共 15 条
  • [1] Nanog and transcriptional networks in embryonic stem cell pluripotency[J]. James A Thomson.Cell Research. 2007(01)
  • [2] Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines
    Fujii, Hiromasa
    Honoki, Kanya
    Tsujiuchi, Toshifumi
    Kido, Akira
    Yoshitani, Kazuhiro
    Takakura, Yoshinori
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 34 (05) : 1381 - 1386
  • [3] The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype
    Xiao, Yi
    Ye, Yin
    Yearsley, Kurtis
    Jones, Susie
    Barsky, Sanford H.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2008, 173 (02): : 561 - 574
  • [4] Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87
    Yu, Shi-cang
    Ping, Yi-fang
    Yi, Liang
    Zhou, Zhi-hua
    Chen, Han-hong
    Yao, Xiao-hong
    Gao, Lei
    Wang, Ji Ming
    Bian, Xiu-wu
    [J]. CANCER LETTERS, 2008, 265 (01) : 124 - 134
  • [5] Cancer Stem Cells as Mediators of Treatment Resistance in Brain Tumors: Status and Controversies[J] . Per ?. Sakariassen,Heike Immervoll,Martha Chekenya.Neoplasia . 2007 (11)
  • [6] Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers[J] . M.Mimeault,R.Hauke,P. P.Mehta,S. K.Batra.Journal of Cellular and Molecular Medicine . 2007 (5)
  • [7] Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells
    Hattori, Naoko
    Imao, Yuko
    Nishino, Koichiro
    Hattori, Naka
    Ohgane, Jun
    Yagi, Shintaro
    Tanaka, Satoshi
    Shiota, Kunio
    [J]. GENES TO CELLS, 2007, 12 (03) : 387 - 396
  • [8] Strategies to eliminate cancer stem cells: Clinical implications[J] . Carol Ann Huff,William H. Matsui,B. Douglas Smith,Richard J. Jones.European Journal of Cancer . 2006 (9)
  • [9] Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
    Takahashi, Kazutoshi
    Yamanaka, Shinya
    [J]. CELL, 2006, 126 (04) : 663 - 676
  • [10] New evidence for the origin of intracranial germ cell tumours from primordial germ cells: expression of pluripotency and cell differentiation markers[J] . CEHoei‐Hansen,ASehested,MJuhler,Y‐FCLau,NESkakkebaek,HLaursen,ERajpert‐de Meyts.J. Pathol. . 2006 (1)